Actinic keratoses and the incidence of occult squamous cell carcinoma: a clinical-histopathologic correlation
- PMID: 17034376
- DOI: 10.1111/j.1524-4725.2006.32287.x
Actinic keratoses and the incidence of occult squamous cell carcinoma: a clinical-histopathologic correlation
Abstract
Background: The ability to clinically diagnose actinic keratoses (AKs) lesions has been taken for granted for some time. The importance of the malignant potential of these lesions is well known. However, a recent Phase IV, multicenter study assessing the long-term benefit of aminolevulinic acid-based photodynamic therapy provided a unique opportunity to prospectively examine the clinical histopathologic correlation of AKs.
Objective: The objective was to characterize the histopathology of clinically diagnosed AK lesions in the study population.
Methods: Punch biopsies of 220 clinically diagnosed untreated AKs were performed at baseline plus 51 lesions unresponsive to treatment (total, 271).
Results: Clinical diagnosis and histopathologic findings agreed in 91% (246/271) of the lesions biopsied. The balance of the biopsied lesions were: (1) benign changes 4% (11/271) and (2) occult cutaneous malignancy in 5% (14/271) of the cases, 12 squamous cell carcinomas and 2 basal cell carcinomas.
Conclusions: In this study, about 1 in 25 clinically diagnosed AK lesions identified by board-certified dermatologist investigator(s) were occult early-stage squamous cell carcinomas on histologic assessment, a fact surmised by the medical community that until now had not been well quantified. These findings should be considered when clinicians decide how to treat and manage AK patients.
Similar articles
-
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.Br J Dermatol. 2006 Dec;155(6):1262-9. doi: 10.1111/j.1365-2133.2006.07520.x. Br J Dermatol. 2006. PMID: 17107399 Clinical Trial.
-
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284. Cancer. 2009. PMID: 19382202
-
Clinical recognition of actinic keratoses in a high-risk population: how good are we?Arch Dermatol. 2005 Apr;141(4):507-9. doi: 10.1001/archderm.141.4.507. Arch Dermatol. 2005. PMID: 15837871
-
Pathology and pathobiology of actinic (solar) keratosis - an update.Br J Dermatol. 2007 Dec;157 Suppl 2:18-20. doi: 10.1111/j.1365-2133.2007.08267.x. Br J Dermatol. 2007. PMID: 18067626 Review.
-
Actinic keratosis is squamous cell carcinoma.South Med J. 2000 Jul;93(7):650-5. South Med J. 2000. PMID: 10923948 Review.
Cited by
-
Actinic keratoses: a comprehensive update.J Clin Aesthet Dermatol. 2009 Jul;2(7):43-8. J Clin Aesthet Dermatol. 2009. PMID: 20729970 Free PMC article.
-
Clinicopathological study of 21 cases of eyelid actinic keratosis.Int Ophthalmol. 2009 Oct;29(5):379-84. doi: 10.1007/s10792-008-9251-1. Epub 2008 Jul 17. Int Ophthalmol. 2009. PMID: 18633577
-
Where Artificial Intelligence Can Take Us in the Management and Understanding of Cancerization Fields.Cancers (Basel). 2023 Nov 2;15(21):5264. doi: 10.3390/cancers15215264. Cancers (Basel). 2023. PMID: 37958437 Free PMC article.
-
A randomized, double-blind, placebo-controlled clinical trial evaluating Dermytol(®) cream for the treatment of actinic keratoses.Clin Cosmet Investig Dermatol. 2014 Aug 7;7:215-24. doi: 10.2147/CCID.S63067. eCollection 2014. Clin Cosmet Investig Dermatol. 2014. PMID: 25143750 Free PMC article.
-
Devastating effect of untreated facial squamous cell carcinoma.Proc (Bayl Univ Med Cent). 2021 May 20;34(5):610-612. doi: 10.1080/08998280.2021.1925065. eCollection 2021 Sep. Proc (Bayl Univ Med Cent). 2021. PMID: 34456488 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical